You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
步長製藥(603858.SH):擬6400萬元對長睿生物進行增資
格隆匯 03-01 20:24

格隆匯3月1日丨步長製藥(603858.SH)發佈,公司第四屆董事會第二十三次會議審議通過《關於增資長睿生物技術(成都有限公司的議案》,同意公司擬出資6,400萬元對長睿生物進行增資。本次增資完成後,長睿生物的註冊資本將由3,600萬元增加至10,000萬元。現根據市場需求及項目進展,公司擬於長睿生物增資完成後,收購成都遠睿所持有長睿生物8%股權,蒲曉平(公司董事、副總裁、董事會祕書)、楊春、馬崇旭對本次收購進行跟投,收購成都遠睿所持有長睿生物2.1%股權。

本次投資重組可增強長睿生物資金實力,以便開展相關業務,符合公司發展戰略規劃和長遠利益,培育新的利潤增長點,增強公司可持續發展能力。有利於公司大健康戰略的順利推進,為公司及股東創造最大價值。本次與關聯人共同投資有利於降低公司股權投資業務風險,強化股權投資相關人員的風險約束和激勵,有利於實現經營者與所有者的有機結合。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account